FDA issued a Warning Letter to Jilin Shulan Synthetic Pharmaceutical Co. Ltd. on 5/14/2018 as a result of this inspection.
483 Jilin Shulan Synthetic Pharmaceutical Nov 2017

483 Jilin Shulan Synthetic Pharmaceutical Nov 2017

Latorie Jones FDA$119.00 - Available Now

FDA investigators audited the Jilin Shulan Synthetic Pharmaceutical - Jilin, China facility and issued inspectional observations (via FDA 483) on 10 Nov 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 10 Nov 2017
  • Location: Jilin, China
  • FEI: 3003091092
Add To Cart